Selecta Biosciences Overview
- Year Founded
-
2008
- Status
-
Acquired/Merged
- Employees
-
52
- Latest Deal Type
-
M&A
Selecta Biosciences General Information
Description
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Contact Information
Website
www.selectabio.com(Operating Subsidiary)
Corporate Office
- 65 Grove Street
- Watertown, MA 02472
- United States
Corporate Office
- 65 Grove Street
- Watertown, MA 02472
- United States
Selecta Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 19. Merger/Acquisition | 13-Nov-2023 | Completed | Generating Revenue | |||
| 18. PIPE | 28-Jul-2020 | Completed | Generating Revenue | |||
| 17. PIPE | 19-Dec-2019 | Completed | Generating Revenue | |||
| 16. Secondary Transaction - Open Market | Completed | Generating Revenue | ||||
| 15. Secondary Transaction - Open Market | Completed | Generating Revenue | ||||
| 14. Secondary Transaction - Open Market | Completed | Generating Revenue | ||||
| 13. Debt - General | 14-Sep-2017 | Completed | Generating Revenue | |||
| 12. PIPE | 27-Jun-2017 | Completed | Generating Revenue | |||
| 11. Secondary Transaction - Open Market | 21-Apr-2017 | $218M | Completed | Generating Revenue | ||
| 10. IPO | 22-Jun-2016 | $70M | $218M | Completed | Generating Revenue |
Selecta Biosciences Comparisons
Industry
Financing
Details
Selecta Biosciences Competitors (40)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Agenus | Formerly VC-backed | Lexington, MA | ||||
| TG Therapeutics | Corporation | Morrisville, NC | ||||
| CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| BioAtla | Formerly VC-backed | San Diego, CA |
Selecta Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Selecta Biosciences Patents
Selecta Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| FR-1023205-A | Support for the rest of a seated traveler | Inactive | 10-Aug-1950 |
Selecta Biosciences Executive Team (21)
| Name | Title | Board Seat |
|---|---|---|
| Blaine Davis | Chief Financial Officer, Finance | |
| Carsten Brunn | Chief Executive Officer, President & Board Member |
Selecta Biosciences Board Members (20)
| Name | Representing | Role | Since |
|---|---|---|---|
| Carrie Cox | Self | Chairman & Board Member | |
| Carsten Brunn | Self | Chief Executive Officer, President & Board Member | |
| Nishan de Silva MD | Self | Board Member | |
| Patrick Zenner | Self | Board Member | |
| Scott Myers | Self | Board Member |
Selecta Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Selecta Biosciences Former Investors (26)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AJU IB Investment | Venture Capital | Minority | ||
| Amzak Capital Management | Family Office | Minority | ||
| Amzak Health | Venture Capital | Minority | ||
| BVF Partners | Hedge Fund | Minority | ||
| Bill & Melinda Gates Foundation | Not-For-Profit Venture Capital | Minority |
Selecta Biosciences Investments & Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Cartesian Therapeutics | 13-Nov-2023 | Drug Discovery | |||
| Cyrus Biotechnology | 05-Oct-2021 | Later Stage VC | Biotechnology |
Selecta Biosciences FAQs
-
When was Selecta Biosciences founded?
Selecta Biosciences was founded in 2008.
-
Who is the founder of Selecta Biosciences?
Ulrich Andrian Ph.D is the founder of Selecta Biosciences.
-
Who is the CEO of Selecta Biosciences?
Carsten Brunn is the CEO of Selecta Biosciences.
-
Where is Selecta Biosciences headquartered?
Selecta Biosciences is headquartered in Watertown, MA.
-
What is the size of Selecta Biosciences?
Selecta Biosciences has 52 total employees.
-
What industry is Selecta Biosciences in?
Selecta Biosciences’s primary industry is Drug Discovery.
-
Is Selecta Biosciences a private or public company?
Selecta Biosciences is a Private company.
-
What is Selecta Biosciences’s current revenue?
The current revenue for Selecta Biosciences is .
-
How much funding has Selecta Biosciences raised over time?
Selecta Biosciences has raised $398M.
-
Who are Selecta Biosciences’s investors?
AJU IB Investment, Amzak Capital Management, Amzak Health, BVF Partners, and Bill & Melinda Gates Foundation are 5 of 26 investors who have invested in Selecta Biosciences.
-
Who are Selecta Biosciences’s competitors?
Agenus, TG Therapeutics, CytomX Therapeutics, Inovio Pharmaceuticals, and BioAtla are some of the 40 competitors of Selecta Biosciences.
-
When was Selecta Biosciences acquired?
Selecta Biosciences was acquired on 13-Nov-2023.
-
Who acquired Selecta Biosciences?
Selecta Biosciences was acquired by Cartesian Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
